Sunitinib, Sorafenib, Bevacizumab

They are multi tyrosin Kinase Inhibitor, but none of them is against ROS1

Map: A patient with Urothelial cancer (1038)
Node: 19709
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway